BioDelivery Sciences International, Inc. (BDSI)
-NasdaqCM 4.20 
0.14(3.23%) May 22, 4:00PM EDT
| Prev Close: | 4.34 |
|---|
| Open: | 4.30 |
|---|
| Bid: | 4.04 x 500 |
|---|
| Ask: | 5.65 x 1400 |
|---|
| 1y Target Est: | 8.61 |
|---|
| Beta: | 3.17 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 4.16 - 4.45 |
|---|
| 52wk Range: | 3.12 - 6.89 |
|---|
| Volume: | 332,828 |
|---|
| Avg Vol (3m): | 220,675 |
|---|
| Market Cap: | 159.58M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.55 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BIODELIVERY SCIENCES INTERNATIONAL INC FinancialsEDGAR Online Financials(Fri, May 17)
- BDSI Makes Notable Cross Below Critical Moving Averageat TheStreet(Fri, May 17)
- BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 FinancialsPR Newswire(Thu, May 9)
- BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Thu, May 9)
- BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 9)
- BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care ConferencePR Newswire(Tue, May 7)
- Hedge Funds Are Buying These 3 Biotech Small Caps Trading Below Lowest Target Priceat Seeking Alpha(Wed, May 1)
- BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial StateEDGAR Online(Mon, Apr 29)
- BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of DirectorsPR Newswire(Mon, Apr 29)
- Should You Buy Reckitt Benckiser Today?at Motley Fool(Thu, Apr 11)
- 2 Biotech Stocks Under $10 to Watchat TheStreet(Thu, Apr 11)
- BioDelivery Sciences initiated with a Buy at Janney Capitalat theflyonthewall.com(Thu, Apr 11)
- BioDelivery On Track For Mid-Year NDA Filingat Seeking Alpha(Wed, Apr 10)
- 3 Companies Aiming For The $1.2B Opioid Addiction Marketat Seeking Alpha(Sun, Apr 7)
- BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD DiscEDGAR Online(Mon, Apr 1)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 4.16 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.02 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.34 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapeutics in the areas of pain management and oncology supportive care.
View More